4
Changes in Ownership
TScan Therapeutics, Inc. Filed Acc 0000899243-22-039506
Chief Financial Officer bought 6,000 shares at an average $1.54 ($9,217)
From the SEC's structured data for this filing
Trades in this filing
Silver Brian M. · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-12-27 | Purchase : show line 1 in the form | +2,842 | $1.50 | $4,276 | 29,727 | D |
| 2022-12-28 | Purchase : show line 2 in the form | +3,158 | $1.56 | $4,941 | 32,885 | D |
| Open-market purchases · 6,000 sh · avg $1.54 · $9,217 | ||||||
Loading xslF345X03/doc4.xml…